Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway
出版年份 2021 全文链接
标题
Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway
作者
关键词
Cancer cachexia, Alantolactone, Muscle atrophy, Fat lipolysis, STAT3, NF-κB
出版物
PHYTOMEDICINE
Volume 95, Issue -, Pages 153858
出版商
Elsevier BV
发表日期
2021-11-16
DOI
10.1016/j.phymed.2021.153858
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia
- (2021) Shanshan Lu et al. Journal of Cachexia Sarcopenia and Muscle
- Alantolactone Suppresses Proliferation and the Inflammatory Response in Human HaCaT Keratinocytes and Ameliorates Imiquimod-Induced Skin Lesions in a Psoriasis-Like Mouse Model
- (2021) Wen-Ho Chuo et al. Life-Basel
- Alantolactone mitigates renal injury induced by diabetes via inhibition of high glucose-mediated inflammatory response and macrophage infiltration
- (2020) Yu Zhu et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Nutrition interventions to treat low muscle mass in cancer
- (2020) Carla M. Prado et al. Journal of Cachexia Sarcopenia and Muscle
- Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia
- (2020) Surendra K. Shukla et al. CANCER LETTERS
- Alantolactone induces apoptosis in THP‐1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway
- (2020) Bashir Ahmad et al. Chemical Biology & Drug Design
- Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro
- (2020) Zhijuan Ge et al. Journal of Natural Medicines
- Phytotherapy for Cachexia: Where Do We Stand?
- (2020) Kenny Kuchta et al. Frontiers in Pharmacology
- Cancer Cachexia: Definition, Staging, and Emerging Treatments
- (2020) Jun Ni et al. Cancer Management and Research
- IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
- (2019) Dong Liu et al. Skeletal Muscle
- Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
- (2019) Wan-li Zhang et al. ACTA PHARMACOLOGICA SINICA
- Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma
- (2019) Xiaodong Jia et al. HEPATOLOGY
- Anti-Neuroinflammatory Effect of Alantolactone through the Suppression of the NF-κB and MAPK Signaling Pathways
- (2019) Tan et al. Cells
- Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway
- (2019) Wenjun Hu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients
- (2019) Jun Han et al. Nutrition & Metabolism
- Cancer cachexia: Diagnosis, assessment, and treatment
- (2018) Mohammadamin Sadeghi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Alantolactone suppresses APOC3 expression and alters lipid homeostasis in L02 liver cells
- (2018) Meiting Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
- (2018) Michael H. Gerber et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
- (2018) Hailun Zheng et al. MOLECULAR CARCINOGENESIS
- Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice
- (2017) Makoto Yoshimura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis
- (2017) Shuang Gao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades
- (2017) Xun Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TNF-α and cancer cachexia: Molecular insights and clinical implications
- (2017) Hetal J. Patel et al. LIFE SCIENCES
- Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
- (2017) Marco Segatto et al. Nature Communications
- Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis
- (2017) Chunxiao Miao et al. Frontiers in Pharmacology
- Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients
- (2016) Hikaru Sato et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma
- (2016) A Miller et al. ONCOGENE
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
- (2015) Jaemoo Chun et al. CANCER LETTERS
- Inactivating STAT3: bad for tumor, good for muscle
- (2015) Rosanna Piccirillo et al. CELL CYCLE
- Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia
- (2015) Kleiton Augusto Santos Silva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
- (2015) Danielle N. Seto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status
- (2015) Lei Sun et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Pancreatic Cancer-Induced Cachexia Is Jak2-Dependent in Mice
- (2014) Marine Gilabert et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The genus Inula and their metabolites: From ethnopharmacological to medicinal uses
- (2014) Ana M.L. Seca et al. JOURNAL OF ETHNOPHARMACOLOGY
- Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
- (2014) Míriam Toledo et al. PLoS One
- Modeling human cancer cachexia in colon 26 tumor-bearing adult mice
- (2014) Erin E. Talbert et al. Journal of Cachexia Sarcopenia and Muscle
- Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
- (2013) Azhar Rasul et al. TheScientificWorldJOURNAL
- Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells
- (2012) Jaemoo Chun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Alantolactone Induces Apoptosis in HepG2 Cells through GSH Depletion, Inhibition of STAT3 Activation, and Mitochondrial Dysfunction
- (2012) Muhammad Khan et al. Biomed Research International
- IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse
- (2012) James P White et al. Skeletal Muscle
- Anti-inflammatory therapies in cancer cachexia
- (2011) Josep M. Argilés et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Ultrasound-assisted extraction of alantolactone and isoalantolactone from Inula helenium roots
- (2010) Antoaneta Trendafilova et al. Pharmacognosy Magazine
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started